Atrasentan: targeting the endothelin axis in prostate cancer.
about
Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancerNovel targeted therapeutics for metastatic castration-resistant prostate cancer.Cancer and the tumor microenvironment: a review of an essential relationship.A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancerAtrasentan: a novel and rationally designed therapeutic alternative in the management of cancer.Therapeutic potential of endothelin receptor modulators: lessons from human clinical trials.Endothelin-A receptor antagonists in prostate cancer treatment-a meta-analysis.Dual effects of rifampin on the pharmacokinetics of atrasentan.
P2860
Q29006772-2E17A23F-197C-4E62-8BDE-FCEE325A54DFQ33642278-874059A1-45FD-44B9-A832-E3B7F32DC00EQ33806357-060A5F0D-8660-4BAE-AF65-4DE25A1E01CEQ34999463-6E6BAE30-EBB2-4FEB-A54D-155A358B2C8CQ36185608-F74DFE39-F72B-46E6-B697-70CCE7713BAAQ37573815-79E17711-B7F4-4C1B-81FD-55748EBD652FQ40846608-8F219DDC-42E8-4C71-8FF8-4EA0C78989C3Q48473609-7349B677-D6AA-4B98-B7E1-E60C014CA242
P2860
Atrasentan: targeting the endothelin axis in prostate cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Atrasentan: targeting the endothelin axis in prostate cancer.
@ast
Atrasentan: targeting the endothelin axis in prostate cancer.
@en
type
label
Atrasentan: targeting the endothelin axis in prostate cancer.
@ast
Atrasentan: targeting the endothelin axis in prostate cancer.
@en
prefLabel
Atrasentan: targeting the endothelin axis in prostate cancer.
@ast
Atrasentan: targeting the endothelin axis in prostate cancer.
@en
P2860
P1476
Atrasentan: targeting the endothelin axis in prostate cancer.
@en
P2093
Antonio Jimeno
Michael Carducci
P2860
P304
P356
10.1517/13543784.13.12.1631
P407
P577
2004-12-01T00:00:00Z